Mesoblast (MEOBF, $0.84) was one of top quarterly gainers, jumping +34 to $0.84 per share. A.I.dvisor analyzed 894 stocks in the Biotechnology Industry over the last three months, and discovered that of them (3) charted an Uptrend while of them (6) trended down.